Anti-Angiogenesis Drugs in Diabetic Retinopathy

E-ISSN： 1873-4316|12|3|369-372

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.12, Iss.3, 2011-03, pp. : 369-372

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging drugs for diabetic retinopathy

By Mohamed Quresh Wong Tien Y

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 4, 2008-12 ,pp. : 675-694

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for diabetic retinopathy

By Pipis Antonios Scholl Stefan Augustin Albert J

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 4, 2011-12 ,pp. : 669-681

Informa Healthcare

Access to resources Recommend Favorite

Anti-angiogenic therapy of proliferative diabetic retinopathy

By Danis R.P. Ciulla T.A. Criswell M. Pratt L.

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 3, 2001-03 ,pp. : 395-407

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of anti-oxidants and diabetic retinopathy

By Kowluru Renu A Kennedy Alexander

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 9, 2001-09 ,pp. : 1665-1676

Informa Healthcare

Access to resources Recommend Favorite

Strategies for blocking angiogenesis in diabetic retinopathy: from basic science to clinical practice

By Hernández Cristina Simó Rafael

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 8, 2007-08 ,pp. : 1209-1226

Informa Healthcare

Access to resources Recommend Favorite